Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream
- PMID: 14616497
- DOI: 10.1046/j.1440-0960.2003.00010.x
Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream
Abstract
A 77-year-old woman with a large porokeratosis of Mibelli on the left shin was successfully treated with topical 5% imiquimod cream applied to the entire lesion once daily without occlusion three times a week. A strong inflammatory reaction was achieved in 6 weeks of treatment. The lesion had been present for approximately 6 years and prior treatments included curettage and electrocautery, cryotherapy and topical 5-fluorouracil under occlusion. At the end of treatment with topical 5% imiquimod cream, punch biopsy was negative for porokeratosis. The lesion healed without scarring. At 24-month follow up there had been no sign of clinical recurrence.
Similar articles
-
Porokeratosis of Mibelli of the axillae: treatment with topical imiquimod.J Dermatolog Treat. 2006;17(5):319-20. doi: 10.1080/09546630600944116. J Dermatolog Treat. 2006. PMID: 17092865
-
A case of porokeratosis ptychotropica: successful treatment with topical 5% imiquimod cream.Clin Exp Dermatol. 2017 Oct;42(7):839-841. doi: 10.1111/ced.13117. Epub 2017 May 22. Clin Exp Dermatol. 2017. PMID: 28543397 No abstract available.
-
Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream.Dermatol Surg. 2006 Jun;32(6):858-61. doi: 10.1111/j.1524-4725.2006.32176.x. Dermatol Surg. 2006. PMID: 16792657 No abstract available.
-
Topical imiquimod: a review of its use in genital warts.Drugs. 1999 Aug;58(2):375-90. doi: 10.2165/00003495-199958020-00017. Drugs. 1999. PMID: 10473026 Review.
-
A review of imiquimod 5% cream for the treatment of various dermatological conditions.Clin Exp Dermatol. 2003 Nov;28 Suppl 1:1-3. doi: 10.1046/j.1365-2230.28.s1.1.x. Clin Exp Dermatol. 2003. PMID: 14616801 Review. No abstract available.
Cited by
-
Porokeratoses-A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants.Metabolites. 2023 Nov 26;13(12):1176. doi: 10.3390/metabo13121176. Metabolites. 2023. PMID: 38132857 Free PMC article. Review.
-
Soluble Factors and Receptors Involved in Skin Innate Immunity-What Do We Know So Far?Biomedicines. 2021 Nov 29;9(12):1795. doi: 10.3390/biomedicines9121795. Biomedicines. 2021. PMID: 34944611 Free PMC article. Review.
-
Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.Drugs. 2007;67(15):2187-210. doi: 10.2165/00003495-200767150-00006. Drugs. 2007. PMID: 17927284 Review.
-
Clinical Study of Porokeratosis Associated with Immunosuppressive Therapy in Renal Transplant Recipients.Ann Dermatol. 2008 Dec;20(4):167-71. doi: 10.5021/ad.2008.20.4.167. Epub 2008 Dec 31. Ann Dermatol. 2008. PMID: 27303185 Free PMC article.
-
Treatment of porokeratosis of Mibelli with combined use of topical fluorouracil and calcipotriene.JAAD Case Rep. 2021 Jan 23;9:54-56. doi: 10.1016/j.jdcr.2021.01.012. eCollection 2021 Mar. JAAD Case Rep. 2021. PMID: 33644282 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources